Stay updated on Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page.
Latest updates to the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page
- Check6 days agoChange DetectedThe website has updated its contact information, adding new contacts including Sharanya Chandrasekhar, M.S. and Izael Nino, M.S., while removing previous principal investigators and their contact details, along with a revision update from v2.13.3 to v2.14.0.SummaryDifference3%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check42 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information on who can answer questions about joining the study and where it is taking place, with a reference to the Contacts and Locations section.SummaryDifference3%
- Check57 days agoChange DetectedSeveral key resources and links related to genetics, breast cancer, and clinical studies have been removed, which may impact access to important medical information.SummaryDifference5%
- Check64 days agoChange DetectedNew resources related to genetics and breast cancer have been added, including links to MedlinePlus and DailyMed, which may be of particular interest to users seeking health information.SummaryDifference0.5%
- Check71 days agoChange DetectedThe website has been updated to version v2.12.2, introducing new features for downloading data in various formats and allowing users to select specific fields for export.SummaryDifference4%
Stay in the know with updates to Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page.